Among them, programmed death ligand 1 (PD-L1), an immune checkpoint protein in the cancer-immune cycle, is expressed on the surface of tumor cells (TC) and tumor-infiltrating immune cells (IC) to downregulate T cell function (69). The gene discussed is CD274; the disease is neoplasm.